TGA issues new warning of VTE risk with oral contraceptives containing dienogest, and updates contraception advice for tamoxifen The Therapeutic Goods Administration has issued new advice regarding the risk of venous thromboembolism when using combined oral contraceptives containing dienogest. Dienogest, a progestogen, is available in two combined oral contraceptives (COCs) in Australia. These are marketed
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.